These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 39008006)

  • 1. Drug Interactions between Traditional Chinese Medicines and Cardiovascular Drugs.
    Shen Q; Chen W; Wang W; Kang S; Du Y; Shi J; Yao L; Li W
    Eur J Drug Metab Pharmacokinet; 2024 Sep; 49(5):559-582. PubMed ID: 39008006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traditional Chinese Medicine-based Treatment in Cardiovascular Disease: Potential Mechanisms of Action.
    Li L; Ran Y; Wen J; Lu Y; Liu S; Li H; Cheng M
    Curr Pharm Biotechnol; 2024; 25(17):2186-2199. PubMed ID: 38347793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traditional Chinese medicine and mitophagy: A novel approach for cardiovascular disease management.
    Wang J; Zou J; Shi Y; Zeng N; Guo D; Wang H; Zhao C; Luan F; Zhang X; Sun J
    Phytomedicine; 2024 Jun; 128():155472. PubMed ID: 38461630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances of traditional Chinese medicine against cardiovascular disease: overview and potential mechanisms.
    Dai J; Qiu L; Lu Y; Li M
    Front Endocrinol (Lausanne); 2024; 15():1366285. PubMed ID: 39403576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the mechanism of TCM formulae in the treatment of different types of coronary heart disease by network pharmacology and machining learning.
    Yang J; Tian S; Zhao J; Zhang W
    Pharmacol Res; 2020 Sep; 159():105034. PubMed ID: 32565312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between clopidogrel and traditional Chinese medicine.
    Hu Y; Wang J
    J Thromb Thrombolysis; 2019 Oct; 48(3):491-499. PubMed ID: 31471773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Traditional Chinese Medicine for Cardiovascular Disease: Evidence and Potential Mechanisms.
    Hao P; Jiang F; Cheng J; Ma L; Zhang Y; Zhao Y
    J Am Coll Cardiol; 2017 Jun; 69(24):2952-2966. PubMed ID: 28619197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of antithrombotic herbal medicines with Western cardiovascular drugs.
    Zuo HL; Linghu KG; Wang YL; Liu KM; Gao Y; Yu H; Yang FQ; Hu YJ
    Pharmacol Res; 2020 Sep; 159():104963. PubMed ID: 32497719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: Pharmacology and mechanisms.
    Li X; Li L; Lei W; Chua HZ; Li Z; Huang X; Wang Q; Li N; Zhang H
    Biomed Pharmacother; 2021 Oct; 142():111979. PubMed ID: 34358754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research initiative of new thought on "main effect" of TCM formulae--new thinking on mechanism of compound action and compatibility mechanism of Chinese herbal compound formulae].
    Weng XG; Li YJ; Chen Y; Yang Q; Wang YJ; Li Q; Cai WY; Zhu XX
    Zhongguo Zhong Yao Za Zhi; 2018 Sep; 43(18):3782-3786. PubMed ID: 30384546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF).
    Hou YZ; Wang S; Zhao ZQ; Wang XL; Li B; Soh SB; Mao JY
    Trials; 2013 May; 14():138. PubMed ID: 23672353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic herb-drug interactions with traditional Chinese medicine: progress, causes of conflicting results and suggestions for future research.
    Ma BL; Ma YM
    Drug Metab Rev; 2016; 48(1):1-26. PubMed ID: 26915920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between Traditional Chinese Medicine and Anticoagulant/Antiplatelet Drugs.
    Li J; Liang Q; Sun G
    Curr Drug Metab; 2019; 20(9):701-713. PubMed ID: 31453781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial.
    Wang J; Shi J; Wei J; Wang J; Gao K; Li X; Chen J; Li S; Zhao H; Wang W
    Trials; 2017 Oct; 18(1):468. PubMed ID: 29017565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome).
    Guo L; Yuan H; Zhang D; Zhang J; Hua Q; Ma X; Chen K
    Medicine (Baltimore); 2020 May; 99(21):e20271. PubMed ID: 32481305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
    Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P
    J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traditional Chinese medicine: herb-drug interactions with aspirin.
    Lim JW; Chee SX; Wong WJ; He QL; Lau TC
    Singapore Med J; 2018 May; 59(5):230-239. PubMed ID: 29796686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interaction of Chinese and western medicines in treatment of cardiovascular diseases].
    Zhang Y; Yang L; Li JM; Liu JX; Zhang Y
    Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(19):5121-5130. PubMed ID: 36472019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine.
    Gao ZY; Xu H; Shi DZ; Wen C; Liu BY
    J Ethnopharmacol; 2012 Jun; 141(2):578-83. PubMed ID: 21924336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormesis as a mechanistic approach to understanding herbal treatments in traditional Chinese medicine.
    Wang D; Calabrese EJ; Lian B; Lin Z; Calabrese V
    Pharmacol Ther; 2018 Apr; 184():42-50. PubMed ID: 29080703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.